质子泵抑制剂使用与胃癌风险的韩国全国性队列研究
该研究基于韩国国民健康保险服务数据库2002至2013年数据,比较新型PPI使用者与其他药物使用者的胃癌发生率。在幽门螺杆菌根除者中,PPI使用超过180天仍与胃癌显著相关(HR 2.22,95%CI 1.05-4.67,p=0.036)。结论提示胃癌高风险地区长期使用PPI应谨慎。
要点
- PPI使用与胃癌发生率增加相关,HR 2.37(95%CI 1.56-3.68)。
- 胃癌发生率随PPI使用时长增加呈上升趋势。
- 幽门螺杆菌根除后长期使用PPI仍与胃癌相关。
核心结论
- PPI使用与胃癌相关,且不受幽门螺杆菌根除状态影响。
- 胃癌高风险地区长期使用PPI应谨慎。
研究设计与样本
- 基于韩国国民健康保险服务数据库2002至2013年原始版与通用数据模型版的人群队列研究。
- 采用Cox比例风险模型比较PPI新使用者与其他药物使用者暴露1年后的胃癌发生率。
主要发现
- 胃癌发生率随PPI使用时长增加呈上升趋势。
临床怎么用
- 在胃癌高风险地区,应谨慎评估长期PPI使用的必要性。
- 幽门螺杆菌根除后仍需长期PPI者,应关注胃癌风险监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The association between proton pump inhibitor (PPI) use and gastric cancer related to Helicobacter pylori eradication has not been fully investigated in geographical regions with high risk of gastric cancer. We aimed to evaluate the association between PPIs and gastric cancer in Korea. DESIGN: This study analysed the original and common data model versions of the Korean National Health Insurance Service database from 2002 to 2013. We compared the incidence rates of gastric cancer after 1-year drug exposure, between new users of PPIs and other drugs excluding PPIs, by Cox proportional hazards model. We also analysed the incidence of gastric cancer among PPI users after H. pylori eradication. RESULTS: The analysis included 11 741 patients in matched PPI and non-PPI cohorts after large-scale propensity score matching. During a median follow-up of 4.3 years, PPI use was associated with a 2.37-fold increased incidence of gastric cancer (PPI≥30 days vs non-PPI; 118/51 813 person-years vs 40/49 729 person-years; HR 2.37, 95% CI 1.56 to 3.68, p=0.001). The incidence rates of gastric cancer showed an increasing trend parallel to the duration of PPI use. In H. pylori-eradicated subjects, the incidence of gastric cancer was significantly associated with PPI use over 180 days compared with the non-PPI group (PPI≥180 days vs non-PPI; 30/12 470 person-years vs 9/7814 person-years; HR 2.22, 95% CI 1.05 to 4.67, p=0.036). CONCLUSION: PPI use was associated with gastric cancer, regardless of H. pylori eradication status. Long-term PPIs should be used with caution in high-risk regions for gastric cancer.
引用
- Seo SI, Park CH, You SC, et al. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut. 2021. PMID: 33975868. doi:10.1136/gutjnl-2020-323845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。